Insider trade

Director sold ~$66K of UTHR shares in the open market

Traded Sep 14, 2026 · Filed Sep 16, 2026

Why it stands out

A board member of United Therapeutics sold $66K of United Therapeutics shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Director$25K–$100K

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$65,752

Shares × reported transaction price

Timing vs results

40 days after results of Aug 5, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

This transaction was executed in multiple trades at prices ranging from $505.76 to $505.985. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

yesterday

Derivative exercise or conversion — not an open-market buy.

Scheduled in advanceyesterday

Scheduled in advanceyesterday